Projects per year
Personal profile
Research
I am the leader of the Lyskjær Group at the Department of Molecular Medicine (MOMA), a research group dedicated to renal cancer. Our research focuses on personalized medicine for renal cancer patient management. We aim to identify biomarkers that can improve treatment decisions and ultimately enhance survival for patients with renal cell carcinoma (RCC). We pursue this goal through comprehensive, multi-omic analyses of the tumor, its microenvironment, as well as matched blood and fecal samples.
External positions
Postdoc, University College London
1 Sept 2018 → 15 Jan 2020
Areas of expertise
- Kidney Cancer
- Translationel Research
- Liquid Biopsy
- Biomarker Development
Fingerprint
Dive into the research topics where Iben Lyskjær Heimann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Harnessing the molecular landscape to improve renal cancer patient management
Heimann, I. L. (PI)
01/02/2023 → 01/07/2028
Project: Research
-
Development of a device for electroporation from the tip of an endoscope: A novel, minimal invasive surgical procedure
Ørntoft, M.-B. W. (Participant), Heimann, I. L. (Participant), Callesen, M. M. (Participant), Rasmussen, M. H. (Participant), Uhre, V. (Participant) & Geert, T. (Participant)
01/10/2015 → 01/01/2018
Project: Research
-
Inducible Colorectal Cancer in a Porcine Model
Callesen, M. M. (Participant), Heimann, I. L. (Participant), Ørntoft, M.-B. W. (Participant) & Andersen, C. L. (Participant)
01/10/2014 → 30/11/2016
Project: Research
-
First-line sunitinib for metastatic renal cell carcinoma, a 15-year single institution real-world evidence study
Haman, M., Ahrenfeldt, J., Lyskjær, I. & Fristrup, N., 2025, (E-pub / Early view) In: Urologic Oncology: Seminars and Original Investigations. 7 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma
Jespersen, J., Lindgaard, C., Ahrenfeldt, J., Lyskjær, I. & Jensen, L. E. I., 9 Jan 2025, (E-pub / Early view) In: Nature Reviews. Urology. 210.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
3 Citations (Scopus) -
Reply to 'Enhancing spatial transcriptomics in clear-cell renal cell carcinoma'
Jespersen, J. & Lyskjær, I., 27 Aug 2025, (E-pub / Early view) In: Nature Reviews. Urology.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
-
Titrating Cabozantinib in Metastatic Renal Cell Carcinoma Patients Using Goldilocks Principle: A Real-World Evidence Study
Thybo, M. A., Ahrenfeldt, J., Lyskjær, I. & Fristrup, N., Dec 2025, In: Clinical Genitourinary Cancer. 23, 6, p. 102419 102419.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
-
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa study
Ahrenfeldt, J., Jespersen, J., Lyngstrand, J. E., Iisager, L., Keller, A. K., Fristrup, N., Laurberg, T. & Lyskjær, I., May 2025, In: European Journal of Epidemiology. 40, 5, p. 527-536 10 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access2 Citations (Scopus)